experspadmin

Timing of Laboratory Monitoring for Tumor Lysis Syndrome During Chronic Lymphocytic Leukemia Treatment
Oncology

Timing of Laboratory Monitoring for Tumor Lysis Syndrome During Chronic Lymphocytic Leukemia Treatment

patient care perspectives
By Jeff Sharman, MD
Pharmacologic and Nonpharmacologic Interventions for Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Hepatology

Pharmacologic and Nonpharmacologic Interventions for Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis

expert roundtables
By Arun J. Sanyal, MD; Ashwani K. Singal, MD, MS, AGAF, FACG, FAASLD; Raymond T. Chung, MD
Current Perspectives on Risk Stratification in Nonalcoholic Fatty Liver Disease
Hepatology

Current Perspectives on Risk Stratification in Nonalcoholic Fatty Liver Disease

expert roundtables
By Arun J. Sanyal, MD; Ashwani K. Singal, MD, MS, AGAF, FACG, FAASLD; Raymond T. Chung, MD
Personalized Medicine for Nonalcoholic Fatty Liver Disease
Hepatology

Personalized Medicine for Nonalcoholic Fatty Liver Disease

expert roundtables
By Arun J. Sanyal, MD; Ashwani K. Singal, MD, MS, AGAF, FACG, FAASLD; Raymond T. Chung, MD
Liver Fibrosis: Markers, Calculators, Tests, and Prognostic Tools
Hepatology

Liver Fibrosis: Markers, Calculators, Tests, and Prognostic Tools

expert roundtables
By Arun J. Sanyal, MD; Ashwani K. Singal, MD, MS, AGAF, FACG, FAASLD; Raymond T. Chung, MD
Load More